MARINUS PHARMACEUTICALS, INC. Additional Paid in Capital
MARINUS PHARMACEUTICALS, INC. had Additional Paid in Capital of $603.85 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2024-11-12
- 2024-09-30: Additional Paid in Capital $603.85M.
- 2024-06-30: Additional Paid in Capital $599.02M.
- 2024-03-31: Additional Paid in Capital $594.11M.
- 2023-12-31: Additional Paid in Capital $588.66M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2024-09-30 | $603.85M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $599.02M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $594.11M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $588.66M 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $584.71M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $554.59M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $546.17M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $542.43M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $474.13M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $470.22M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $466.13M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $459.85M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $456.56M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $453.61M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $449.90M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $444.62M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $373.14M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $371.05M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $306.12M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $295.12M 10-K · filed 2021-03-09 | $295.06M 10-K · filed 2020-03-16 |
| 2019-09-30 | $254.18M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $252.89M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $251.63M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $249.73M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $206.45M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $205.28M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $203.92M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $202.79M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $202.07M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $152.09M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $150.49M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $147.29M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $146.49M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $145.66M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $144.95M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $144.09M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $115.22M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $114.48M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $114.06M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $113.48M 10-K · filed 2016-03-07 | |
| 2014-09-30 | $112.94M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $1.20M 10-Q · filed 2014-10-10 | |
| 2013-12-31 | $1.12M 10-K · filed 2015-03-12 | $1.12M 10-Q · filed 2014-10-10 |